Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Trikafta
Pharma
Vertex's Casgevy launch progresses as CF drugs post solid growth
Vertex's Casgevy launch appears to be outpacing that of its bluebird rival Lyfgenia. Meanwhile, Vertex's cystic fibrosis business continues to soar.
Fraiser Kansteiner
May 7, 2024 11:23am
Vertex's sales of Trikafta hit $8.9B thanks to label expansion
Feb 6, 2024 12:39pm
In 'historic' nod, UK signs off on Vertex, CRISPR's gene therapy
Nov 16, 2023 11:45am
NICE rejects cost effectiveness of Vertex's cystic fibrosis meds
Nov 6, 2023 2:42pm
Vertex's CEO scored a major pay bump in 2021
Apr 8, 2022 11:10am
Is the cost of Vertex's Trikafta hampering CF treatment?
Feb 14, 2022 11:46am